Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Bull-like who wrote (8136)	7/19/1999 1:00:00 PM
From: B.REVERE	Respond to of 9523

Actually, Pfizer should easily beat estimates next quarter. Viagra sales were slammed last summer when the media jumped all over the 100 deaths reported from those who took the drug. The media conveniently sidestepped the issue that most of these deaths were dismissed by the FDa's investigation as bogus and not directly related to the drug itself. They also never addressed the fact that these most of these individuals either didn't follow the warnings on the label or had a recent physical to test the stress on their heart. Look for a big quarter from PFE as worldwide "v" sales smoke last years' by a wide margin. Throw in Celebrex and increasing lipitor alliance revenues and this is a nobrainer. Later, Long term pfe holder.